One hundred and twenty-one centers screened 395 subjects and assigned all of them to latanoprost/timolol FC (Figure 1). In all, 391 subjects received at least one dose of the FC and were included ...
(RTTNews) - Glenmark Pharmaceuticals Ltd. (GLENMARK.NS), Friday announced that it has introduced Latanoprost Ophthalmic Solution, 0.005 percent, a bioequivalent and therapeutically equivalent ...
The purpose of the present study was to identify predictors of an additional 10% intraocular pressure (IOP) reduction after 12 weeks of treatment with latanoprost/timolol fixed combination (FC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback